VI-0609 not checked

VIVUS LLC

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
1 active
1 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma
Main trialPhase 2
“A phase 2 multicenter study of VI-0609 vs BiCNU in the BEAM high-intensity conditioning regimen for AHCT in subjects with lymphomas.”In the company’s words, NCT06915246 on ClinicalTrials.gov
Copy of
Bicnu (Avet Lifesciences)Tested side by side with the original in NCT06915246

Other drugs for Lymphoma

All 308 drugs for Lymphoma

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 2Recruiting 31 Mar 2027 A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow VI-0609

Following is part of Solo: you see every change to VI-0609 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in